Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Clinical trial NCT02355431 · WITHDRAWN

Trial details

NCT number

NCT02355431

Sponsor

Incyte Corporation

Status

WITHDRAWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-12-01

Primary completion

2015-09-01

Enrollment

0

View on ClinicalTrials.gov